Cost-effectiveness of interferon alfa 2b and ribavirin in the treatment of chronic hepatitis C [1] (multiple letters)

W. Ray Kim, John J. Poterucha

Research output: Contribution to journalLetter

6 Scopus citations
Original languageEnglish (US)
Pages (from-to)807-808
Number of pages2
Issue number3
StatePublished - Mar 8 2000

ASJC Scopus subject areas

  • Hepatology

Cite this